Short Interest in Reviva Pharmaceuticals Sees Notable Reduction As of February 28, 2025, Reviva Pharmaceuticals' short interest fell 10.8% to 3.79 million shares, representing 15.56% of its float. The short interest ratio now stands at 1.0, suggesting improved sentiment. Institutional investors, including Citadel Advisors, remain active in short positions.45